Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $644.2400 (1.92%) ($632.2100 - $650.0000) on Fri. Jul. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.59% (three month average) | RSI | 63 | Latest Price | $644.2400(1.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 1.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(39%) IVW(38%) IWF(37%) | Factors Impacting REGN price | REGN will decline at least -1.295% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-7%) TBT(-6%) IYT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.295% (StdDev 2.59%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $632.83(1.8%) | 10 Day Moving Average | $633.21(1.74%) | 20 Day Moving Average | $626.91(2.76%) | To recent high | 0% | To recent low | 24.9% | Market Cap | $68.308b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |